Literature DB >> 6825534

Diagnostic value of serum bile acids and routine liver function tests in hepatobiliary diseases. Sensitivity, specificity, and predictive value.

R Ferraris, G Colombatti, M T Fiorentini, R Carosso, W Arossa, M De La Pierre.   

Abstract

Total serum bile acids measured by enzymatic fluorometry and routine liver function tests were determined in a large population including 97 healthy subjects, 138 patients free of hepatobiliary diseases but affected by other diseases, and 344 patients with mild or severe hepatobiliary diseases. In order to define the diagnostic value and some operational characteristics of serum bile acids, sensitivity, specificity, and several predictive value tables for increasing cutoff levels of serum bile acids were calculated by means of a computer program. Serum bile acids and aspartate aminotransferase were found to be similar in sensitivity, specificity, and predictive value. Serum aspartate aminotransferase was found to be more suitable than serum bile acids in detecting mild hepatobiliary diseases, whereas serum bile acids were more sensitive than routine liver tests in the evaluation of severe hepatobiliary diseases. In view of its ability to detect severe hepatobiliary diseases, serum bile acids test may play a decisive role in clinical practice (eg, decision to perform a liver biopsy).

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6825534     DOI: 10.1007/bf01315142

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  18 in total

1.  MEASUREMENT OF HUMAN SERUM BILE ACIDS BY GAS-LIQUID CHROMATOGRAPHY.

Authors:  D H SANDBERG; J SJOEVALL; K SJOEVALL; D A TURNER
Journal:  J Lipid Res       Date:  1965-04       Impact factor: 5.922

2.  A simple and sensitive assay of total serum bile acids.

Authors:  F Mashige; K Imai; T Osuga
Journal:  Clin Chim Acta       Date:  1976-07-01       Impact factor: 3.786

3.  A fluorimetric and enzymatic method for the estimation of serum total bile acids.

Authors:  G M Murphy; B H Billing; D N Baron
Journal:  J Clin Pathol       Date:  1970-10       Impact factor: 3.411

4.  Assessment of activity in chronic active liver disease. Serum bile acids compared with conventional tests and histology.

Authors:  M G Korman; A F Hofmann; W H Summerskill
Journal:  N Engl J Med       Date:  1974-06-20       Impact factor: 91.245

5.  Radioimmunoassay of conjugated cholyl bile acids in serum.

Authors:  W J Simmonds; M G Korman; V L Go; A F Hofmann
Journal:  Gastroenterology       Date:  1973-11       Impact factor: 22.682

6.  [Fasting and post-prandial serum bile acids as liver function tests in chronic liver diseases (author's transl)].

Authors:  R Y Poupon; R E Poupon; S Erlinger; F Darnis
Journal:  Gastroenterol Clin Biol       Date:  1978-11

7.  Serum bile acids in primary biliary cirrhosis.

Authors:  J R Bloomer; R M Allen; G Klatskin
Journal:  Arch Intern Med       Date:  1976-01

8.  Diagnostic value of serum bile acids.

Authors:  N B Javitt
Journal:  Clin Gastroenterol       Date:  1977-01

9.  Clinical value of serum bile acid levels in chronic hepatitis.

Authors:  M B Jones; S Weinstock; R L Koretz; K J Lewin; J Higgins; G L Gitnick
Journal:  Dig Dis Sci       Date:  1981-11       Impact factor: 3.199

10.  Diagnostic significance of fasting serum bile acid in liver disease.

Authors:  C Hirayama; T Irisa; K Arimura; M Nakamura
Journal:  Acta Hepatogastroenterol (Stuttg)       Date:  1976 Nov-Dec
View more
  10 in total

1.  Individual serum bile acids in apprentice spray painters in association with solvent exposure.

Authors:  J J Liu; C L Bai; A M Williamson; S X Qu; H Hamdan; N H Stacey
Journal:  Int Arch Occup Environ Health       Date:  1996       Impact factor: 3.015

2.  The pharmacokinetics of caffeine and its dimethylxanthine metabolites in patients with chronic liver disease.

Authors:  N R Scott; D Stambuk; J Chakraborty; V Marks; M Y Morgan
Journal:  Br J Clin Pharmacol       Date:  1989-02       Impact factor: 4.335

3.  Colorimetric enzymatic measurement of serum total 3 alpha-hydroxy bile acid concentrations without extraction.

Authors:  M Y Qureshi; S M Smith; G M Murphy
Journal:  J Clin Pathol       Date:  1984-03       Impact factor: 3.411

4.  Measurement of bile acid half-life using [75Se]HCAT in health and intestinal diseases. Comparison with [75Se]HCAT abdominal retention methods.

Authors:  R Ferraris; G Galatola; A Barlotta; R Pellerito; M Fracchia; F Cottino; M de la Pierre
Journal:  Dig Dis Sci       Date:  1992-02       Impact factor: 3.199

5.  Diagnostic value of serum immunoreactive conjugated cholic or chenodeoxycholic acids in detecting hepatobiliary diseases. Comparison with levels of 3 alpha-hydroxy bile acids determined enzymatically and with routine liver tests.

Authors:  R Ferraris; M T Fiorentini; G Galatola; P Rolfo; M De la Pierre
Journal:  Dig Dis Sci       Date:  1987-08       Impact factor: 3.199

6.  Reference intervals for preprandial and postprandial serum bile acid in adult rhesus macaques (Macaca mulatta).

Authors:  Marie-Josee M F Lemoy; Diccon R Westworth; Amir Ardeshir; Ross P Tarara
Journal:  J Am Assoc Lab Anim Sci       Date:  2013-07       Impact factor: 1.232

7.  Revised cutoff values of ALT and HBV DNA level can better differentiate HBeAg (-) chronic inactive HBV patients from active carriers.

Authors:  Bushra Ijaz; Waqar Ahmad; Fouzia T Javed; Sana Gull; Sajida Hassan
Journal:  Virol J       Date:  2011-02-27       Impact factor: 4.099

8.  Analytical evaluation of three enzymatic assays for measuring total bile acids in plasma using a fully-automated clinical chemistry platform.

Authors:  Elisa Danese; Gian Luca Salvagno; Davide Negrini; Giorgio Brocco; Martina Montagnana; Giuseppe Lippi
Journal:  PLoS One       Date:  2017-06-08       Impact factor: 3.240

9.  Dynamic Metabolomics Study of the Bile Acid Pathway During Perioperative Primary Hepatic Carcinoma Following Liver Transplantation.

Authors:  Weiguo Sui; Qing Gan; Fuhua Liu; Minglin Ou; Bingguo Wang; Songbai Liao; Liusheng Lai; Huaizhou Chen; Ming Yang; Yong Dai
Journal:  Ann Transplant       Date:  2020-06-23       Impact factor: 1.530

10.  A synthetic biology-based device prevents liver injury in mice.

Authors:  Peng Bai; Haifeng Ye; Mingqi Xie; Pratik Saxena; Henryk Zulewski; Ghislaine Charpin-El Hamri; Valentin Djonov; Martin Fussenegger
Journal:  J Hepatol       Date:  2016-04-09       Impact factor: 25.083

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.